Goldman Sachs Upgrades Hospira To Neutral
February 06, 2015 at 07:42 AM EST
Analysts at Goldman Sachs upgraded Hospira Inc. (NYSE: HSP) from Sell to Neutral. The price target for Hospira has been raised from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.